Cannabis chemistry grows at the ACS


A small but growing movement to establish a division for cannabis chemists within the American Chemical Society (ACS) has scored a major victory with the establishment of a cannabis chemistry subdivision (CANN). The development comes in response to substantial recent growth in the medical and commercial cannabis industries in the US.

cannabis plant

Members of the cannabis chemistry subdivision will voice their opinions on ACS's policy recommendations © Shutterstock

The new subdivision is in the chemical health and safety (CHAS) division and started life as the cannabis chemistry committee within the ACS’s small chemical business division. That committee came about as a result of a campaign that began in September 2014, when Ezra Pryor – an ACS member and president of Ezchem cannabis consultancy – started a petition to create a division.

The subdivision’s location within the CHAS should be useful because that division provides expertise in laboratory safety, chemical management and chemical safety practices. Pryor also emphasises that members of CANN will have a say in what kind of cannabis programming is presented at ACS meetings, and they will be able to voice opinions on society policy recommendations.

Since 2011, the number of cannabis testing laboratories in the US has grown from two to more than two dozen. Pryor is concerned about the current lack of knowledge on approved methods for analysing cannabis, noting that there are several sets of standardised procedures.


Related Content

High hopes for ACS cannabis division

28 April 2015 News and Analysis

news image

An effort to create a cannabis division within the American Chemical Society is gaining momentum

Cannabis chemists look for professional recognition

16 October 2014 News and Analysis

news image

The American Chemical Society is being petitioned to form a division to help develop standards in the field

Most Commented

WHO clarifies glyphosate risks

23 May 2016 Business

news image

UN and WHO panel conclude the herbicide glyphosate is ‘unlikely’ to cause cancer at realistic exposure levels

Large HIV vaccine trial to launch in South Africa

24 May 2016 News and Analysis

news image

US funding agency will enlist 5400 people for HIV vaccine study in South Africa in November